Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,798 JPY | -2.91% | -2.34% | +23.92% |
Mar. 22 | Esperion, Daiichi Get EU Committee Recommendation For Nilemdo, Nustendi Label Update | MT |
Mar. 22 | Esperion Therapeutics Gets CHMP Positive Opinion for Cholesterol Medications | DJ |
Sales 2024 * | 1,581B 10.44B | Sales 2025 * | 1,758B 11.61B | Capitalization | 9,534B 62.94B |
---|---|---|---|---|---|
Net income 2024 * | 168B 1.11B | Net income 2025 * | 190B 1.26B | EV / Sales 2024 * | 5.68 x |
Net cash position 2024 * | 556B 3.67B | Net cash position 2025 * | 595B 3.93B | EV / Sales 2025 * | 5.08 x |
P/E ratio 2024 * |
56.8
x | P/E ratio 2025 * |
50.2
x | Employees | 17,435 |
Yield 2024 * |
0.91% | Yield 2025 * |
1.04% | Free-Float | 97.04% |
Latest transcript on Daiichi Sankyo Co., Ltd.
1 day | -2.91% | ||
1 week | -2.34% | ||
Current month | -3.54% | ||
1 month | -5.01% | ||
3 months | +23.92% | ||
6 months | +14.54% | ||
Current year | +23.92% |
Managers | Title | Age | Since |
---|---|---|---|
Sunao Manabe
CEO | Chief Executive Officer | 69 | 07-03-31 |
Hiroyuki Okuzawa
DFI | Director of Finance/CFO | 61 | 17-03-31 |
Ken Takeshita
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Noritaka Uji
CHM | Chairman | 75 | 14-05-31 |
Sawako Nohara
BRD | Director/Board Member | 66 | 19-05-31 |
Kazuaki Kama
BRD | Director/Board Member | 75 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
25.16% | 14 M€ | +10.37% | ||
4.18% | 245 M€ | +19.57% | ||
3.32% | 174 M€ | -.--% | - | |
3.32% | 51 M€ | -.--% | - | |
3.24% | 15 M€ | +18.60% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4,798 | -2.91% | 4 154 000 |
24-03-27 | 4,972 | +1.97% | 4,500,400 |
24-03-26 | 4,876 | +1.12% | 2,918,500 |
24-03-25 | 4,822 | -1.85% | 2,968,900 |
24-03-22 | 4,913 | 0.00% | 4,215,600 |
Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.92% | 62.98B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.71% | 210B | |
+1.40% | 210B | |
-6.71% | 201B | |
-3.51% | 157B |